{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:17:23Z","timestamp":1783538243661,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer New York","isbn-type":[{"value":"9781493977031","type":"print"},{"value":"9781493977048","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7704-8_13","type":"book-chapter","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T10:22:26Z","timestamp":1520331746000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Amyloid PET Imaging: Standardization and Integration with Other Alzheimer\u2019s Disease Biomarkers"],"prefix":"10.1007","author":[{"given":"Silvia","family":"Morbelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging and Alzheimer\u2019s Association workgroup. Alzheimers Dement 7:270\u2013279","journal-title":"Alzheimers Dement"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C et al (2014) Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol 13:614\u2013629","journal-title":"Lancet Neurol"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1474-4422(15)00093-9","volume":"14","author":"S Teipel","year":"2015","unstructured":"Teipel S, Drzezga A, Grothe MJ et al (2015) Multimodal imaging in Alzheimer\u2019s disease: validity and usefulness for early detection. Lancet Neurol 14:1037\u20131353","journal-title":"Lancet Neurol"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC et al (2015) The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 11:11\u201315","journal-title":"Alzheimers Dement"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10072-015-2079-3","volume":"36","author":"UP Guerra","year":"2015","unstructured":"Guerra UP, Nobili FM, Padovani A et al (2015) Recommendations from the Italian Interdisciplinary Working Group (AIMN, AIP, SINDEM) for the utilization of amyloid imaging in clinical practice. Neurol Sci 36:1075\u20131081","journal-title":"Neurol Sci"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","volume":"57","author":"S Minoshima","year":"2016","unstructured":"Minoshima S, Drzezga AE, Barthel H et al (2016) SNMMI procedure standard\/EANM practice guideline for amyloid PET imaging of the brain 1.0. J Nucl Med 57:1316\u20131322","journal-title":"J Nucl Med"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00259-016-3426-1","volume":"43","author":"V Garibotto","year":"2016","unstructured":"Garibotto V, Morbelli S, Pagani M (2016) Erratum to: dual-phase amyloid PET: hitting two birds with one stone. Eur J Nucl Med Mol Imaging 43:1747","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0006-8993(00)02945-0","volume":"886","author":"PJ Magistretti","year":"2000","unstructured":"Magistretti PJ (2000) Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling. Brain Res 886:108\u2013112","journal-title":"Brain Res"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/brain\/awt142","volume":"136","author":"R Ni","year":"2013","unstructured":"Ni R, Gillberg PG, Bergfors A et al (2013) Amyloid tracers detect multiple binding sites in Alzheimer\u2019s disease brain tissue. Brain 136:2217\u20132227","journal-title":"Brain"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00259-011-2051-2","volume":"39","author":"IT Hsiao","year":"2012","unstructured":"Hsiao IT, Huang CC, Hsieh CJ et al (2012) Correlation of early-phase 18F-florbetapir (AV-45\/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging 39:613\u2013620","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2967\/jnumed.108.060756","volume":"50","author":"M Koole","year":"2009","unstructured":"Koole M, Lewis DM, Buckley C et al (2009) Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med 50:818\u2013822","journal-title":"J Nucl Med"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2967\/jnumed.108.055756","volume":"50","author":"GJ O\u2019Keefe","year":"2009","unstructured":"O\u2019Keefe GJ, Saunder TH, Ng S et al (2009) Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172. J Nucl Med 50:309\u2013315","journal-title":"J Nucl Med"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3233\/JAD-160232","volume":"54","author":"A Chincarini","year":"2016","unstructured":"Chincarini A, Sensi F, Rei L et al (2016) Alzheimer\u2019s Disease Neuroimaging Initiative. Standardized uptake value ratio-independent evaluation of brain amyloidosis. J Alzheimers Dis 54:1437\u20131457","journal-title":"J Alzheimers Dis"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","volume":"31","author":"PE Kinahan","year":"2010","unstructured":"Kinahan PE, Fletcher JW (2010) Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR 31:496\u2013505","journal-title":"Semin Ultrasound CT MR"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol 11:669\u2013678","journal-title":"Lancet Neurol"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","volume":"41","author":"SM Landau","year":"2014","unstructured":"Landau SM, Thomas BA, Thurfjell L et al (2014) Alzheimer\u2019s Disease Neuroimaging Initiative. Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers. Eur J Nucl Med Mol Imaging 41:1398\u20131407","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.2967\/jnumed.112.113654","volume":"54","author":"BN Berckel van","year":"2013","unstructured":"van Berckel BN, Ossenkoppele R, Tolboom N et al (2013) Longitudinal amyloid imaging using 11C-PiB: methodologic considerations. J Nucl Med 54:1570\u20131576","journal-title":"J Nucl Med"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734\u2013746","journal-title":"Lancet Neurol"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"e-1","DOI":"10.1016\/j.jalz.2013.01.002","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson KA, Minoshima S, Bohnen NI et al (2013) Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association. Alzheimers Dement 9:e-1\u2013e-16","journal-title":"Alzheimers Dement"}],"container-title":["Methods in Molecular Biology","Biomarkers for Alzheimer\u2019s Disease Drug Development"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7704-8_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T11:33:21Z","timestamp":1533641601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7704-8_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493977031","9781493977048"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7704-8_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}